Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatol Kontush

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 6, 2016
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3cLeonardo Gomez Rosso, Marie Lhomme, Tomas Meroño, et al.
Biomaterials Advances|February 9, 2025
High-density lipoprotein-like nanoparticles with cationic cholesterol derivatives for siRNA deliveryAliaksei Ihnatsyeu-Kachan, Olga Sharko, Andrei Bekish, et al.
Clinical Chemistry|January 27, 2011
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular eventsRobert S Rosenson, H Bryan Brewer, M John Chapman, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 2, 2016
Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemiaTomás Meroño, Carolane Dauteuille, Walter Tetzlaff, et al.
Journal of Clinical Lipidology|April 21, 2019
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiencyEmile Zakiev, Fabiana Rached, Marie Lhomme, et al.
Atherosclerosis|March 10, 2026
LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trialIsabella Bonilha, Marcos Yukio Yoshinaga, Adriano Britto Chaves-Filho, et al.
Journal of Lipid Research|November 19, 2017
Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphateLaurence Perségol, Maryam Darabi, Carolane Dauteuille, et al.
Atherosclerosis|June 27, 2016
Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritisEliana Botta, Tomás Meroño, Carla Saucedo, et al.
Atherosclerosis|December 3, 2014
Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammationLeonardo Gómez Rosso, Marie Lhomme, Tomas Meroño, et al.
Rheumatology and Therapy|April 3, 2021
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational StudyFlorencia S Pierini, Eliana Botta, Enrique R Soriano, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|November 6, 2016
Poor glycemic control in type 2 diabetes enhances functional and compositional alterations of small, dense HDL3cLeonardo Gomez Rosso, Marie Lhomme, Tomas Meroño, et al.
Biomaterials Advances|February 9, 2025
High-density lipoprotein-like nanoparticles with cationic cholesterol derivatives for siRNA deliveryAliaksei Ihnatsyeu-Kachan, Olga Sharko, Andrei Bekish, et al.
Clinical Chemistry|January 27, 2011
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular eventsRobert S Rosenson, H Bryan Brewer, M John Chapman, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 2, 2016
Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemiaTomás Meroño, Carolane Dauteuille, Walter Tetzlaff, et al.
Journal of Clinical Lipidology|April 21, 2019
Distinct phospholipid and sphingolipid species are linked to altered HDL function in apolipoprotein A-I deficiencyEmile Zakiev, Fabiana Rached, Marie Lhomme, et al.
Atherosclerosis|March 10, 2026
LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trialIsabella Bonilha, Marcos Yukio Yoshinaga, Adriano Britto Chaves-Filho, et al.
Journal of Lipid Research|November 19, 2017
Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphateLaurence Perségol, Maryam Darabi, Carolane Dauteuille, et al.
Atherosclerosis|June 27, 2016
Associations between disease activity, markers of HDL functionality and arterial stiffness in patients with rheumatoid arthritisEliana Botta, Tomás Meroño, Carla Saucedo, et al.
Atherosclerosis|December 3, 2014
Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammationLeonardo Gómez Rosso, Marie Lhomme, Tomas Meroño, et al.
Rheumatology and Therapy|April 3, 2021
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational StudyFlorencia S Pierini, Eliana Botta, Enrique R Soriano, et al.
Pageof 14